With the view to gain continuous competitive edge and to discharge its commitment towards meeting the healthcare needs by providing innovative products, the organisation has been continuously launching innovative and value added brands. During the year under review the company has launched Paclitrust, Docetrust, Gemtrust, Zoletrust & Temotrust in Oncology segment thereby assuring treatment for cancer viz. breast cancer, brain tumor, ovarian cancer, pancreatic cancer, prostrate cancer & colorectal cancer.